Devon Energy DVN breaks its long-term downtrend
The energy sector started 2025 on a high note, with the popular ETF Energy Select Sector SPDR Fund NYSEARCA:XLE (NYSE:) up 5.36% year to date, making it the best performing sector since the start of the year. Devon Energy Corporation (NYSE:) has been a standout in this area, up more than 12% this year.
As one of the largest independent oil and gas producers in the United States, Devon operates in highly productive regions like the Delaware Basin.
Devon’s dividend yield is particularly attractive, combining a fixed and variable component linked to free cash flow. Although its forward yield stands at 4.13%, it could rise significantly if oil prices continue to rise. After spending much of 2024 in decline, Devon recently broke out of a long-term downtrend, breaking through a critical resistance level.
This technical change suggests further upside if the stock establishes a base above its breakout zone.
Analysts are bullish, with a Moderate Buy rating and a price target of $49.43, providing further upside potential.
CVS Health stands out among early outperformers in 2025
CVS Health Corp (NYSE:). NYSE:CVS, a dominant player in the U.S. healthcare industry, is best known for its CVS Pharmacy, CVS Caremark and Aetna locations. The company faced significant challenges in 2024, including declining demand for COVID-related products and rising costs related to its growing Medicare Advantage (MA) plans.
These headwinds have caused the stock to underperform, but the narrative is starting to change. A recent government proposal to increase MA payments in 2026 has renewed optimism, helping stocks climb nearly 15% year-to-date as of Monday’s close, defying the market crisis in its together.
On the technical side, CVS broke out from a consolidation base near $45 and is now approaching its 50-day simple moving average, signaling strengthening momentum. CVS offers an impressive dividend yield of 5.16% for income-oriented investors, coupled with an attractive P/E ratio of 13.08.
Analysts are bullish, maintaining a moderate buy rating and projecting a nearly 33% upside from…
..